{"resourceType":"Bundle","type":"searchset","entry":[{"resource":{"resourceType":"Parameters","id":"ImmDS-2018-0002","parameter":[{"name":"assessentDate","valueDate":"2020-06-29"},{"name":"patient","resource":{"resourceType":"Patient","id":"2018-0002","name":[{"text":"Zoster: Dose #2 of the RZV (Shringrix) vaccine administered at two months after dose #1\nEvaluation_Test_Type: All Valid: Forecast Test\nGeneral_Description: This test case describes when a patient is administered dose #2 of the RZV vaccine at two months after dose #1, that the dose is considered to be valid."}],"gender":"male","birthDate":"1970-05-04"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2018-0002-dose1","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"187","display":"zoster recombinant"}]},"patient":{"reference":"Patient/2018-0002"},"date":"2020-05-04T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2018-0002-dose2","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"187","display":"zoster recombinant"}]},"patient":{"reference":"Patient/2018-0002"},"date":"2020-06-29T00:00:00.000"}}]},"request":{"method":"PUT","url":"Parameters"}},{"resource":{"resourceType":"Parameters","parameter":[{"name":"recommendation","resource":{"resourceType":"ImmunizationRecommendation","patient":{"reference":"Patient/2018-0002"},"recommendation":[{"date":"2020-06-29T00:00:00.000","forecastStatus":{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/ForecastStatus","code":"complete","display":"Complete"}]},"dateCriterion":[{"code":{"coding":[{"system":"http://loinc.org","code":"30981-5","display":"Earliest date to give"}]},"value":"2999-12-31T00:00:00.000"},{"code":{"coding":[{"system":"http://loinc.org","code":"30980-7","display":"Date vaccine due"}]},"value":"2999-12-31T00:00:00.000"},{"code":{"coding":[{"system":"http://loinc.org","code":"59778-1","display":"Date when overdue for immunization"}]},"value":"2999-12-31T00:00:00.000"}],"protocol":{"description":"Evaluation_Test_Type: All Valid: Forecast Test\nForecast_Test_Type: EvaluationNot recommended: series complete\nGeneral_Description: This test case describes when a patient is administered dose #2 of the RZV vaccine at two months after dose #1, that the dose is considered to be valid.","series":"ZOSTER"}}]}}]},"request":{"method":"PUT","url":"Parameters"}}]}